Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds
Saulo Fehelberg Pinto Braga, Viviane Corrêa Santos, Rafael P. Vieira, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114876-114876
Closed Access | Times Cited: 9

Showing 9 citing articles:

Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi
Rúbia Castro Fernandes Melo Reis, Elda Gonçalves dos Santos, Monique Dias Benedetti, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115622-115622
Closed Access | Times Cited: 11
Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and Plasmodium spp.
Pamela Souza Tada da Cunha, Ana Luísa Rodriguez Gini, Chung Man Chin, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1788-1788
Open Access
Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles
Viviane Corrêa Santos, Paulo Gaio Leite, Lucianna Helene Santos, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115498-115498
Closed Access | Times Cited: 7
Structure-Based Discovery of Thiosemicarbazones As SARS-CoV-2 Main Protease Inhibitors
Vinícius Gonçalves Maltarollo, Elany Barbosa da Silva, Thales Kronenberger, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 11, pp. 959-985
Closed Access | Times Cited: 7
Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis
Aloke Saha, Pushpa, Susmita Moitra, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 16, pp. 2135-2169
Closed Access | Times Cited: 4
Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (S, Se) and Their Azole Derivatives against Chagas Disease
Mercedes Rubio-Hernández, Verónica Alcolea, Elany Barbosa da Silva, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19038-19056
Closed Access | Times Cited: 1
Desulfurization of thiosemicarbazones: the role of metal ions and biological implications
Alondra Jiménez-Pérez, Sandra Fernández‐Fariña, Rosa Pedrido, et al.
JBIC Journal of Biological Inorganic Chemistry (2023) Vol. 29, Iss. 1, pp. 3-31
Closed Access | Times Cited: 3
Recent advances in medicinal chemistry of Neglected Tropical Diseases (NTDs)
Edeildo Ferreira da Silva‐Júnior, Peng Zhan
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115714-115714
Closed Access | Times Cited: 2
Nanomolar Activity of Coumarin-3-thiosemicarbazones Targeting Trypanosoma cruzi Cruzain and T. brucei Cathepsin-L-like Protease
Jéssica Alves Nunes, Paulo Fernando da Silva Santos-Júnior, Maria Rebeca Otero Gomes, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117109-117109
Closed Access
Page 1

Scroll to top